Liminatus Pharma, Inc. (LIMN) Stock Forecast 2027–2031
LIMN Price Today
$2.82
LIMN Stock Ratings
LIMN Price Targets
| Month | Close | Total,% |
|---|---|---|
| 2026 | ||
| Nov | $2.85 | 1.06% |
| Dec | $2.87 | 1.77% |
| 2027 | ||
| Jan | $2.88 | 2.13% |
| Feb | $2.86 | 1.42% |
| Mar | $2.87 | 1.77% |
| Apr | $2.89 | 2.48% |
| May | $2.88 | 2.13% |
| Jun | $2.86 | 1.42% |
| Jul | $2.88 | 2.13% |
| Aug | $2.86 | 1.42% |
| Sep | $2.82 | 0.00% |
| Oct | $2.82 | 0.00% |
| Nov | $2.85 | 1.06% |
| Dec | $2.87 | 1.77% |
| 2028 | ||
| Jan | $2.88 | 2.13% |
| Feb | $2.86 | 1.42% |
| Mar | $2.87 | 1.77% |
| Apr | $2.89 | 2.48% |
| May | $2.88 | 2.13% |
| Jun | $2.86 | 1.42% |
| Jul | $2.88 | 2.13% |
| Aug | $2.86 | 1.42% |
| Sep | $2.82 | 0.00% |
| Oct | $2.82 | 0.00% |
| Nov | $2.86 | 1.42% |
| Dec | $2.88 | 2.13% |
| 2029 | ||
| Jan | $2.89 | 2.48% |
| Feb | $2.86 | 1.42% |
| Mar | $2.87 | 1.77% |
| Apr | $2.89 | 2.48% |
| May | $2.88 | 2.13% |
| Jun | $2.87 | 1.77% |
| Jul | $2.88 | 2.13% |
| Aug | $2.86 | 1.42% |
| Sep | $2.82 | 0.00% |
| Oct | $2.83 | 0.35% |
| Nov | $2.86 | 1.42% |
| Dec | $2.88 | 2.13% |
| 2030 | ||
| Jan | $2.89 | 2.48% |
| Feb | $2.87 | 1.77% |
| Mar | $2.88 | 2.13% |
| Apr | $2.90 | 2.84% |
| May | $2.88 | 2.13% |
| Jun | $2.87 | 1.77% |
| Jul | $2.88 | 2.13% |
| Aug | $2.86 | 1.42% |
| Sep | $2.82 | 0.00% |
| Oct | $2.83 | 0.35% |
| Nov | $2.86 | 1.42% |
| Dec | $2.88 | 2.13% |
| 2031 | ||
| Jan | $2.89 | 2.48% |
| Feb | $2.87 | 1.77% |
| Mar | $2.88 | 2.13% |
| Apr | $2.90 | 2.84% |
| May | $2.89 | 2.48% |
| Jun | $2.87 | 1.77% |
| Jul | $2.89 | 2.48% |
| Aug | $2.87 | 1.77% |
| Sep | $2.83 | 0.35% |
| Oct | $2.83 | 0.35% |
The LIMN stock price forecast for 2026 is $2.87, which is a change of +1.77% over today.
The LIMN stock price forecast for 2027 is $2.89, which is a change of +2.48% over today.
The LIMN stock price forecast for 2028 is $2.89, which is a change of +2.48% over today.
The LIMN stock price forecast for 2029 is $2.89, which is a change of +2.48% over today.
The LIMN stock price forecast for 2030 is $2.90, which is a change of +2.84% over today.
The LIMN stock price forecast for 2031 is $2.90, which is a change of +2.84% over today.
Is LIMN Stock a Buy?
Is LIMN Stock a Good Long-Term Investment?
Can LIMN stock reach $200?
LIMN Frequently Asked Questions
What is LIMN stock rated?
Wall Street X rates LIMN a SELL, and the average consensus rating is a NOT AVAILABLE.
What is the price target for LIMN?
Wall Street X has a one year price target of $2.82 for LIMN.
How do I buy shares of LIMN?
To buy shares of LIMN, open an account with an online brokerage, deposit money from your bank, search for “LIMN”, choose the number of shares or dollar amount, and place a trade.
Popular Articles
LIMN forecast data was last updated on by .
Bookmark this page to check for updates:
on iPhone/iPad tap the Share icon 
. Select Add to Favorites, then Add.
on Android tap the 3-dots icon 
at the top right. Tap Add to Favorites, then Add.
on PC press buttons Ctrl + D or click the star 
next to the browser bar at the top.
Trending Stocks This Week
| Loading… |
JOIN OUR NEWSLETTER WAITLIST
Daily trending stocks, portfolio updates, upgrades/downgrades, and latest articles.
LIMN Price Target Calculator
Interactive calculatorAdjust growth and future valuation assumptions to estimate a stock price target.
Stock target = Current price × (1 + annual compounded revenue growth)selected years × (future P/S ÷ current P/S)selected years ÷ selected period. The default annual growth is solved from the final The LIMN stock price forecast for 2026 is $2.87, which is a change of +1.77% over today. The LIMN stock price forecast for 2027 is $2.89, which is a change of +2.48% over today. The LIMN stock price forecast for 2028 is $2.89, which is a change of +2.48% over today. The LIMN stock price forecast for 2029 is $2.89, which is a change of +2.48% over today. The LIMN stock price forecast for 2030 is $2.90, which is a change of +2.84% over today. The LIMN stock price forecast for 2031 is $2.90, which is a change of +2.84% over today.
The red benchmark starts at the same current price and compounds at 10.4% annually. It is an illustrative comparison, not a prediction of S&P 500 returns. Calculations assume constant forecast growth, stable shares outstanding, and no dividends or dilution.
